Please ensure Javascript is enabled for purposes of website accessibility

Kids and COVID: When Will They Be Vaccinated?

By Morgan McSweeney - Mar 31, 2021 at 6:15AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Almost 30% of U.S. adults have received at least one dose of a coronavirus vaccine, but clinical trials of the vaccines' safety and efficacy in children are still in progress.

The pace of vaccination in the U.S. has picked up since the beginning of 2021, and we're currently in a race to inoculate the adult population before new variants spread widely. But as shots make it into arms and the world begins to reopen, we still have more to learn about how the coronavirus infects and spreads throughout a population almost 75 million strong: children. 

Clinical studies of vaccines from companies like Pfizer (PFE 0.78%) and Moderna (MRNA 1.01%) are currently investigating adequate dosage and safety profiles. But in terms of a  timeline, when could we start to think about vaccinating children against COVID-19?

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Pfizer Inc. Stock Quote
Pfizer Inc.
$52.88 (0.78%) $0.41
Moderna, Inc. Stock Quote
Moderna, Inc.
$137.62 (1.01%) $1.37

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/24/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.